Characteristics of patients with dyslipidemia treated in routine care setting in China

Liu, Gordon; Shepherd, Jason F.; Rane, Pallavi; Zhao, Zhongyun; Bailey, Hollie; Williams, Nathan; Qian, Yi

doi:10.1080/21556660.2019.1684926

Cited by 4 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hypertension (HT) was defined based on a previous diagnosis or a systolic pressure ≥ 140 mm Hg or a diastolic pressure ≥ 90 mm Hg [ 13 ]. Dyslipidemia was defined as taking lipid control drugs or low-density lipoprotein (LDL) > 160 mg/dl or high-density lipoprotein (HDL) < 40 mg/dl or cholesterol > 240 mg/dl or triglycerides > 150 mg/dl in a blood test [ 14 ]. Hemoglobin A1c (HbA1c) ≥ 6.5% or a history of glycemic control drugs was defined as hyperglycemia [ 15 ].…”

Section: Methodsmentioning

confidence: 99%

Prevalence and associated factors of corneal arcus in the geriatric population; Tehran geriatric eye study

et al. 2022

View full text Add to dashboard Cite

Purpose To determine the age and sex-standardized prevalence of corneal arcus and its associated factors in a geriatric population. Methods This population-based cross-sectional study was conducted in 2019 in Tehran; the capital of Iran, using a multi-stage stratified random cluster sampling method. All participants underwent a detailed interview, blood pressure measurement, laboratory blood tests, and a complete ocular examination. Results Three thousand three hundred ten of 3791 invitees participated in the study (response rate: 87.31%). The mean age of the participants was 69.35 ± 7.62 years (60–97 years) and 1912 (57.76%) were female. Overall, the age and sex-standardized prevalence (95% CI) of corneal arcus was 44.28% (41.21–47.39). Based on the multiple logistic regression, the odds of corneal arcus were higher in men than in women (OR: 1.51; 95% CI: 1.14–2.00); in the age group ≥ 80 years compared to the age group 60–64 years (OR: 2.44; 95% CI: 1.68–3.53), and in retired people compared to employed individuals (OR: 2.05; 95% CI: 1.31–3.21). Conclusion The present study showed a high prevalence of corneal arcus in the geriatric population. Although various studies have reported a significant relationship between corneal arcus with blood lipid and glucose levels as well as blood pressure, these relationships were not found in the present study.

show abstract

Section: Methodsmentioning

confidence: 99%

Prevalence and associated factors of corneal arcus in the geriatric population; Tehran geriatric eye study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Hypertension was defined as systolic blood pressure (BP) ≥ 140 mm Hg and/or diastolic BP ≥ 90 mm Hg [ 19 ]. Dyslipidemia was defined as total cholesterol of ≥ 5 mmol/L or ≥ 200 mg/dL [ 20 ]. Disease control was defined as the proportion of patients achieving a target BP of ≤ 140/90 mm Hg or cholesterol of ≤ 5 mmol/L or ≤ 200 mg/dL with treatment.…”

Section: Methodsmentioning

confidence: 99%

Challenges faced by patients with dyslipidemia and systemic arterial hypertension in Brazil: a design of the patient journey

Faria-Neto

Yarleque²,

Vieira³

et al. 2022

BMC Cardiovasc Disord

View full text Add to dashboard Cite

Background and objective Non-communicable diseases like systemic arterial hypertension (SAH) and dyslipidemia are poorly studied in terms of patient journey aspects. This semi-systematic review provides evidence synthesis for the management of SAH and dyslipidemia in Brazil and also discusses challenges faced by patients at the local level along with a suggested care approach by local experts. Methods A semi-systematic review using both structured literature databases (Embase and Medline) and unstructured scientific records (WHO, IPD, MOH and Google) on hypertension and dyslipidemia in the English language from 2010 to 2019 was performed by reviewers. After two-level screening based on pre-defined criteria, patient journey touchpoints and prevalence information were extracted from the included articles. Data gaps were bridged through the insights of local experts. Results Prevalence of hypertension and dyslipidemia in Brazil were 23% and 40.8%, respectively. Awareness of dyslipidemia was found in a larger proportion (58.1%) than in SAH (22.2%). Similarly, screening for hypertension (97%) and dyslipidemia (55.4%) were found to be effective, while treatment was (62.9%) and (30.0%) for hypertension and dyslipidemia, respectively. Conclusion There were important gaps on patient awareness and treatment of dyslipidemia and hypertension. Limited patient education, regional disease distribution, and treatment allocation, along with limited resources for diagnosis and treatment are the key challenges.

show abstract

“…[19] Dyslipidemia was de ned as total cholesterol of ≥ 5 mmol/L or ≥ 200 mg/dL. [20] Disease control was de ned as the proportion of patients achieving a target BP of ≤ 140/90 mm Hg or cholesterol of ≤ 5 mmol/L or ≤ 200 mg/dL with treatment.…”

Section: Search Strategy and Selection Criteriamentioning

confidence: 99%

Challenges Faced by Patients with Dyslipidemia and Systemic Arterial Hypertension in Brazil: A Design of the Patient Journey

Neto

Yarleque

Vieira

et al. 2021

Preprint

View full text Add to dashboard Cite

Background & Objective: Non-communicable diseases like systemic arterial hypertension (SAH) and dyslipidemia are poorly studied in terms of patient journey aspects. This semi-systematic review provides evidence synthesis for the management of SAH and dyslipidemia in Brazil and also discusses challenges faced by patients at the local level along with a suggested care approach by local experts.Methods: A semi-systematic review using both structured literature databases (Embase and Medline) and unstructured scientific records (WHO, IPD, MOH and Google) on hypertension and dyslipidemia in the English language from 2010–2019 was performed by reviewers. After two-level screening based on pre-defined criteria, patient journey touchpoints and prevalence information were extracted from the included articles. Data gaps were bridged through the insights of local experts.Conclusion: Limited patient education, regional disease distribution, and treatment allocation, along with limited resources for diagnosis and treatment are the key challenges. To improve overall patient journey considering critical touchpoints, timely and strict adoption of pharmacological treatment guidelines, campaigns for increased patient literacy about healthy diet and lifestyle modification, about the importance of self-reporting for early disease diagnosis, and benefits of treatment adherence are strongly recommended. Also, it is suggested to ensure the availability of skilled resources through continued education to render quality care to cardiovascular patients in Brazil.

show abstract

Characteristics of patients with dyslipidemia treated in routine care setting in China

Cited by 4 publications

References 13 publications

Prevalence and associated factors of corneal arcus in the geriatric population; Tehran geriatric eye study

Prevalence and associated factors of corneal arcus in the geriatric population; Tehran geriatric eye study

Challenges faced by patients with dyslipidemia and systemic arterial hypertension in Brazil: a design of the patient journey

Challenges Faced by Patients with Dyslipidemia and Systemic Arterial Hypertension in Brazil: A Design of the Patient Journey

Contact Info

Product

Resources

About